Scarica l'app Stockscreener
0.9034
0.46%
-0.0042
Pre-mercato:
.94
0.0366
+4.05%
Lucid Diagnostics Inc Borsa (LUCD) Ultime notizie
LUCD|Lucid Diagnostics Inc|Price:0.904|Chg%:-0.003 - TradingKey
Lucid Diagnostics Inc (LUCD) Institutional Confidence - TradingKey
Lucid Diagnostics Inc (LUCD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Lucid Diagnostics Inc (LUCD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Lucid Diagnostics Inc (LUCD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Lucid Diagnostics Inc (LUCD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Lucid Diagnostics Market Sentiment - Benzinga España
TradingKey - TradingKey
Lucid Diagnostics Inc (LUCD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
LUCD|Lucid Diagnostics Inc|Price:0.908|Chg%:-0.038 - TradingKey
AAPL: Apple Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Lucid Diagnostics (LUCD) Drops 6.4% to $0.95 – Testing Key SupportAnalyst Upgrade Stocks - dars.gov.et
Lucid Diagnostics (LUCD) Nears One-Dollar Threshold After Modest DeclineArms Index - dars.gov.et
LUCD Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Lucid Diagnostics (LUCD) Holds Steady Near Support: Can the Modest Uptick Signal a Reversal?Volume Breadth - dars.gov.et
LUCD Q1 2026 Earnings: Significant EPS Miss and No Reported Revenue Raise ConcernsTech Earnings Analysis - dars.gov.et
Lucid Diagnostics (LUCD) Extends Decline: Approaching Key Support at $0.99 After 3.7% DropKeltner Channel - dars.gov.et
Lucid Diagnostics Announces Pricing of Public Offering of Common Stock - GuruFocus
LUCD Q1 2026 Earnings: Significant Earnings Miss as Company Reports No RevenueEstimate Accuracy - DonanımHaber
PAVmed gets 180-day extension to regain Nasdaq listing compliance - MSN
Lucid Diagnostics (LUCD) Edges Higher as Diagnostics Sector Sees Renewed InterestStop Loss Guidance - dars.gov.et
Lucid Diagnostics: Positioned For A Medicare-Driven Inflection (NASDAQ:LUCD) - Seeking Alpha
LUCD News | LUCID DIAGNOSTICS INC (NASDAQ:LUCD) - ChartMill
Lucid Diagnostics Inc.(NasdaqCM:LUCD) dropped from Russell Small Cap Comp Value Benchmark - marketscreener.com
Lucid Diagnostics Inc.(NasdaqCM: LUCD) dropped from Russell 3000 Value Benchmark - marketscreener.com
Lucid Diagnostics Inc.(NasdaqCM: LUCD) dropped from Russell 2500 Value Benchmark - marketscreener.com
Lucid Diagnostics Inc.(NasdaqCM: LUCD) dropped from Russell 2000 Value Benchmark - marketscreener.com
Lucid Diagnostics Q1 2026 Earnings: Wider-Than-Expected Loss Highlights Pre-Revenue Challenges - dars.gov.et
Lucid Diagnostics Inc.(NasdaqCM:LUCD) dropped from Russell Microcap Value Benchmark Index - marketscreener.com
Lucid Diagnostics Inc. Actuals & Estimates (NASDAQ:LUCD) - TradingView
LUCD Forecast — Price Target — Prediction for 2027 - TradingView
Lucid Diagnostics Shareholders Approve Stock Authorization Increase - TipRanks
Lucid Diagnostics (LUCD) boosts authorized shares to 400M and re-elects directors - Stock Titan
LUCD: All proposals passed, including director elections and share authorization increase - TradingView
Transcript : Lucid Diagnostics Inc.Shareholder/Analyst Call - marketscreener.com
Lucid Diagnostics (LUCD) Holds Steady at $1.03: Stock Consolidates Near Key LevelsPre-Earnings Momentum - dars.gov.et
LUCD Q1 2026 Earnings: Wider-Than-Expected Loss Drives Stock Despite No RevenueSubscription Growth Report - dars.gov.et
Top Lucid Diagnostics (LUCD) Competitors 2026 - MarketBeat
Lucid Diagnostics Inc (LUCD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Lucid Diagnostics Inc (LUCD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Lucid Diagnostics Inc (LUCD) Valuation: PE, PB & Fair Value Analysis - TradingKey
LUCD Q1 2026 Earnings: Deep EPS Miss Masks Operational Progress; Stock Edges HigherQuarterly Earnings - DonanımHaber
Lucid Diagnostics (LUCD) Edges Higher, Testing Key Resistance at $1.05Risk Reward Setups - dars.gov.et
LUCD Q1 2026 Earnings: EPS Misses Estimates by 100.7% as Company Reports No RevenueEarnings Turnaround - dars.gov.et
Certain Stock Options of Lucid Diagnostics Inc. are subject to a Lock-Up Agreement Ending on 9-JUN-2026. - marketscreener.com
Lucid Diagnostics misses on revenue, but 2026 growth outlook lights up bull case - MSN
Lucid Diagnostics Misses On Revenue, But 2026 Growth Outlook Lights Up Bull Case - Benzinga
LUCD Maintained by Ascendiant Capital -- Price Target Raised to $9.25 - GuruFocus
LUCD Q1 2026 Earnings: Significant EPS Miss Amid Pre-Revenue Development StageEBITDA Estimate Trend - dars.gov.et
Why Lucid Diagnostics Inc. (LUCD) Faced a Price Target Reduction After Q1 Results - Yahoo Finance
0.79%
4.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):